Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity. - Wikidata - awgldk - TriplyDB

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.

http://www.wikidata.org/entity/Q33912129

about

Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines New perspectives on the role of vitiligo in immune responses to melanoma Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer.Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response.Optimization of a self antigen for presentation of multiple epitopes in cancer immunity Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection.Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo Multiple pathways to tumor immunity and concomitant autoimmunity.Enhanced responses to tumor immunization following total body irradiation are time-dependent Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.Control of human mesothelin-expressing tumors by DNA vaccines.Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.Prevention of autoimmune diabetes by DNA vaccination.Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines.Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination.Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.DNA vaccination: using the patient's immune system to overcome cancer Intradermal naked plasmid DNA immunization: mechanisms of action.Xenogene vaccination in the therapy of cancer.DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma.A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-B*0702 positive patients.CD8(+) T cells sabotage their own memory potential through IFN-γ-dependent modification of the IL-12/IL-15 receptor α axis on dendritic cells.Bioelectric applications for treatment of melanoma.Anti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3α-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons.Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.DNA vaccines for prostate cancer.Risk Factors Including Age, Stage and Anatomic Location that Impact the Outcomes of Patients with Synovial Sarcoma.Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis

P2860

Q24684238-79815F2B-3FFB-414D-BFFD-F7D9BC803EAA Q24804837-243BBDA2-B742-45A7-82E2-2C7A9707D955 Q26738680-63D661D5-91F0-4CFB-9D90-425E1A398036 Q26996799-D61ED7E8-60B9-4A6E-BEF8-E26259AC2EA0 Q33689478-25BF277B-BF99-4AC0-A18F-9F0CB9E874A3 Q33924781-2B5E2430-9FCC-4CBD-A0A2-4CCDA6A1CFE2 Q34522301-55B179DB-981F-45BB-932E-4D3899CDCE7F Q34537491-5865962F-DF63-436B-9146-B9D0C7A5DB15 Q34561877-CB1D4F74-2D4C-4720-A359-F9365002C58E Q34625208-9DD22845-168B-4573-A0FC-E8F701C1D803 Q35005484-BAB285CC-67C0-444B-936F-2374F4FEF707 Q35005947-E60B672B-69EA-4463-8F00-314A8969CE82 Q35070312-07306F69-3AD3-4735-8A22-47E275C0C998 Q35146595-0D9C39A1-F85C-439E-9AAC-A1C746D6D5A2 Q35238497-038319B0-27B4-4A41-B8C2-4C52B4AC56B1 Q35600772-3B765D52-4059-4F21-9F8F-9446AEAAC751 Q35623332-6ABFCEC6-C6D6-419D-9F86-59C47446529F Q35809463-AB84A603-5756-4DC1-A663-E555BAFBA6DD Q35948223-67E86206-3435-494C-A722-564C608233A5 Q36198661-E9D53BD9-96B8-453A-929D-37DEBB8CF28A Q36459336-4F2EBE3E-D02F-4F53-9437-89CE51B18580 Q36696205-F9B3CE6A-45B7-43A1-86EF-FB34BF01A00F Q37825422-A5045A63-5055-4EB7-AD69-549052C1B950 Q37919894-701124A2-16AB-4131-8F45-C3483200E9D7 Q38229368-73D74561-1A78-4A49-93BF-04101975F8FE Q41561252-D6C59BC1-F2CB-408F-AD7A-48F34425D116 Q41679793-E668C82E-43ED-4BE0-941A-1427C1A4D231 Q42031722-42B3E938-709E-4A31-B185-8331082814E6 Q42323649-B42E33AD-7D53-4B62-8E2C-96EED1AB1BFA Q42872841-9B87111C-871E-421A-B995-425F5F0DCC74 Q47731909-159B96AD-67C5-4B6C-92FE-BFC9690F266F Q50222492-2BFCC8B0-56C0-4A02-BADF-E2722EA575A3 Q51142505-B00D8D36-B92E-435F-8838-26F0117EA941 Q55260657-C346A33B-1683-4E38-BF06-9918992597F8 Q58788761-0E74833C-AF60-4C47-AE77-1073365E9061

P2860

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity.

http://www.wikidata.org/entity/Q33912129

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Immunization with DNA coding f ...... ndependent antitumor immunity.

@ast

Immunization with DNA coding f ...... ndependent antitumor immunity.

@en

type

label

Immunization with DNA coding f ...... ndependent antitumor immunity.

@ast

Immunization with DNA coding f ...... ndependent antitumor immunity.

@en

prefLabel

Immunization with DNA coding f ...... ndependent antitumor immunity.

@ast

Immunization with DNA coding f ...... ndependent antitumor immunity.

@en

P1433

Q33912129-39A38096-1F2C-46C1-861D-B05649BF1D23

P1476

Q33912129-35D3014C-42AA-4FB4-9D68-B1465A90102E

P2093

Q33912129-3CC1D10A-D342-4A7D-8D77-134E9B3571A6

Q33912129-80878246-2FF3-42B6-B60C-16AA75B8966D

Q33912129-95465632-B1D8-4BD0-9950-BBED60F83D0E

Q33912129-A355F315-7E36-4C36-A237-FE27CC886283

Q33912129-B040351E-B9C1-4F6C-A855-C860588F49E2

Q33912129-BE97D224-3907-4F81-8E5F-80B3D0877004

Q33912129-CBD6B974-F476-420C-85B1-040CD3B3CC81

Q33912129-D02BB5AD-933A-47F2-9E5A-F776A26D7E0C

Q33912129-DF42984A-5CF1-4D4B-A3EE-F6448A3E1696

P304

Q33912129-3FB5F98A-5780-4008-9DC8-89B2FE9D40B0

P31

Q33912129-DEB74BBB-996F-4B79-AFEE-9F6F927A6C9C

P356

Q33912129-C47DFE53-D40A-44EF-BBDB-29CAE4F3F245

P407

Q33912129-DAA91BC3-82C9-4E39-9C07-E89ED3762496

P433

Q33912129-5E6EAD25-4A11-4052-923F-BF425386F4FB

P478

Q33912129-3F954894-9261-40E9-814A-68E580FF2A73

P577

Q33912129-8A33E3DC-0D18-4493-9FDD-F4233024F5D7

P698

Q33912129-36FB595B-54B9-453B-B9B6-496626276A63

P921

Q33912129-40534C6C-83FE-42C6-AD5D-2E9A2796C09E

P356

MSY.2000.107421

P1433

P1476

Immunization with DNA coding f ...... ndependent antitumor immunity.

@en

P2093

Bowne WB

http://www.w3.org/2001/XMLSchema#string

Dyall R

http://www.w3.org/2001/XMLSchema#string

Gold JS

http://www.w3.org/2001/XMLSchema#string

Hawkins WG

http://www.w3.org/2001/XMLSchema#string

Hoos A

http://www.w3.org/2001/XMLSchema#string

Houghton AN

http://www.w3.org/2001/XMLSchema#string

Lewis JJ

http://www.w3.org/2001/XMLSchema#string

Srinivasan R

http://www.w3.org/2001/XMLSchema#string

Wolchok JD

http://www.w3.org/2001/XMLSchema#string

P304

273-280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1067/MSY.2000.107421

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10923004

http://www.w3.org/2001/XMLSchema#string

P921